List view / Grid view
13 December 2018 | By European Pharmaceutical Review
A blood test could transform the way doctors treat people affected by cystic fibrosis, helping to personalise treatments to individual people...
5 December 2018 | By Iqra Farooq (European Pharmaceutical Review)
A team of Iranian researchers have determined that trastuzumab taken with a heart drug leads to less heart damage in breast cancer patients...
4 December 2018 | By European Pharmaceutical Review
Through a clinical trial, Cleveland researchers have identified how rivaroxaban reduces blood clots in cancer patients and also decreases related deaths...
3 December 2018 | By European Pharmaceutical Review
Researchers have developed a method of using less contrast medium to still obtain high quality images in magnetic resonance imaging (MRI)...
3 December 2018 | By European Pharmaceutical Review
A study has reported results of a clinical trial using CAR-T therapy where over half of the cancer patients were alive two years after the start...
30 November 2018 | By European Pharmaceutical Review
A nanoscale blood test could be used to gain more information from the blood of patients in order to help the identification of cancer in its early stages...
27 November 2018 | By European Pharmaceutical Review
Researchers at Leiden University Medical Center have identified how fractional-dose yellow fever vaccinations protect against the condition for ten years...
26 November 2018 | By European Pharmaceutical Review
MedUni Vienna researchers have developed a way to use retinal imaging to diagnose diabetes, explaining how the technique could be used for other conditions...
21 November 2018 | By European Pharmaceutical Review
Researchers have developed a method of producing extracellular vesicles on a large scale to deliver drugs offering a standardised method of manufacture...
21 November 2018 | By European Pharmaceutical Review
The pharmaceutical industry accounted for 67 percent of the total spending on research and development, with federal government accounting for 22 percent...
19 November 2018 | By European Pharmaceutical Review
Ribociclib, a drug approved to treat breast cancer, could be used to treat one of the deadliest forms of cancer - glioblastoma...
19 November 2018 | By European Pharmaceutical Review
The US Food and Drug Administration has approved first-line treatment for newly diagnosed peripheral T-cell lymphoma using a new review program...
16 November 2018 | By European Pharmaceutical Review
A trial has shown that radiotherapy is more effective when levels of ropidoxuridine in a patients' body reach a certain level...
15 November 2018 | By European Pharmaceutical Review
Researchers have found heart complications in patients diagnosed with bacterial pneumonia are more serious than in patients diagnosed with viral pneumonia...
14 November 2018 | By European Pharmaceutical Review
The antibody ZW25 can bind two distinct regions of the HER2 receptor to block the growth of cancer cells and has shown signs of anti-tumour activity...
Follow: